To experience the full functionality of this website you need JavaScript. Instructions on how to enable JavaScript in your browser can be found here.
goetzpartners advised
McKesson with
Scroll down
goetzpartners was mandated by ITM AG for
on a technology license agreement for medical radioisotopes with China Isotope & Radiation Corporation (CIRC)
goetzpartners was mandated by Vivoryon Therapeutics AG for
on the option agreement and equity commitment for its lead compound to MorphoSys AG
15,000,000 €
goetzpartners was mandated by AlzeCure Pharma for
on the IPO of AlzeCure Pharma on the NASDAQ First North
19,400,000 €